Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Offer Update

19 Oct 2005 14:45

Quadnetics Group PLC19 October 2005 Quadnetics Group PLC19 October 2005 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THEUNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF IRELAND, SOUTH AFRICA OR JAPAN RECOMMENDED OFFER FOR PROTEC PLC As at 1.00pm on 18 October 2005, valid acceptances had been received in respectof 62,855,079 Protec Shares (representing approximately 39.15 per cent. ofProtec's issued share capital). Prior to the posting of the Offer Document, Quadnetics had received irrevocableundertakings from the Protec Directors and certain other Protec Shareholders toaccept the Offer in respect of, in aggregate, 99,758,979 Protec Sharesrepresenting 62.15 per cent. of the existing issued Protec Shares. Of theseirrevocable undertakings the Board has received valid acceptances from, inaggregate, 55,415,275 Protec Shares, representing 34.52 per cent of the existingissued Protec Shares. The Company has received signed forms of acceptance from the remaining ProtecShareholders who gave irrevocable undertakings totalling 44,343,702 ProtecShares representing 27.63 per cent. of the Protec Shares, and expects to receivethe documents of title related to these shares shortly. The Quadnetics Board announces that it is lowering its valid acceptancecondition from 75 per cent. to 50 per cent. of the Protec Shares to which theOffer relates. A further announcement will be made on or before 21 October 2005, being thefirst closing date of the Offer. Enquiries Quadnetics 01527 850080Russ Singleton, Chief ExecutiveNigel Poultney, Finance Director Brewin Dolphin Securities Ltd 0113 241 0130(Financial Adviser and Corporate Broker to Quadnetics)Neil BaldwinKeith Williams Protec 01923 211550Bill Moir, Chief Executive Teather & Greenwood 020 7246 9000(Financial Adviser and Corporate Broker to Protec)Jeff KeatingRob Naylor Media Enquiries Abchurch Communications 0207 398 7700Chris MundenAriane Comstive This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Mar 20114:35 pmRNSAvailability of Report & Accounts
8th Mar 20117:00 amRNSRe: 2009 Group Executive Shared Ownership Plan
4th Mar 20117:00 amRNSPreliminary Results
1st Feb 201111:06 amRNSNotification of Results
7th Jan 20114:02 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSAcquisition
21st Dec 201010:45 amRNSHolding(s) in Company
21st Dec 20107:00 amRNSHolding(s) in Company
16th Dec 20107:00 amRNSChange of Adviser
6th Dec 20107:00 amRNSPost Year End Trading Update
27th Jul 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSInterim Results
21st Jan 201010:36 amRNSContract Win
15th Jan 20102:59 pmRNSREPLACEMENT: Notice of Results
15th Jan 201010:35 amRNSNotice of Results
11th Nov 200910:59 amRNSResult of AGM
5th Nov 20097:00 amRNSTrading Update
9th Sep 20097:00 amRNSPreliminary Results
16th Jun 20097:00 amRNSStructural and Strategic Reorganisation
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.